Senatore, Fortunato
Jagadeesh, Gowraganahalli http://orcid.org/0000-0002-9066-3929
Rose, Martin
Pillai, Venkateswaran C.
Hariharan, Sudharshan
Liu, Ququan
Tzu-Yun, McDowell
Sapru, Mohan K.
Southworth, Mary Ross
Stockbridge, Norman
Clinical trials referenced in this document:
Documents that mention this clinical trial
Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial
https://doi.org/10.1186/s13054-023-04446-1
FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock
https://doi.org/10.1007/s40256-018-0297-9
Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock
https://doi.org/10.1186/s13613-023-01227-5
Article History
First Online: 25 August 2018
Change Date: 1 March 2019
Change Type: Correction
Change Details: The author name that previously read
Compliance with Ethical Standards
:
: No external funds were used in the preparation of this manuscript.
: Fortunato Senatore, Gowraganahalli Jagadeesh, Martin Rose, Venkateswaran C. Pillai, Sudharshan Hariharan, Ququan Liu, McDowell Tzu-Yun, Mohan K. Sapru, Mary Ross Southworth, and Norman Stockbridge declare that they have no conflicts of interest relevant to the content of this article.
Free to read: This content has been made available to all.